Increasing recommended testing compliance for persons with type II diabetes in primary care

dc.contributor.advisorChairperson, Graduate Committee: Elizabeth A. Johnsonen
dc.contributor.authorFleming, Brandi Lynnen
dc.contributor.otherThis is a manuscript style paper that includes co-authored chapters.en
dc.coverage.spatialMontanaen
dc.date.accessioned2024-09-23T13:35:40Z
dc.date.available2024-09-23T13:35:40Z
dc.date.issued2024en
dc.description.abstractBackground: Type II diabetes affects one in 14 Montanans (Centers for Disease Control and Prevention (CDC), 2023). The CDC estimates annual direct and indirect costs of diabetes in Montana exceed $800 million (2023). Constraints persist when incorporating National Quality Forum measures and Healthy People 2030 objective guidance to address known challenges in managing Type II diabetes in a community setting due to minimal resources and lack of workflow appraisal. The rurality and radical weather patterns in Montana pose challenges for sustaining healthy diets and regular exercise. Purpose: The quality improvement project aims at generating consistent clinical decision support system (CDSS) electronic health record platform (EHR) reminders, streamlining workflow processes, and delaying Type II diabetes' concomitant conditions. Methods: A Plan-Do-Study-Act (PDSA) cycle employing Amazing Charts EHR to consistent clinical decision support system reminders, workflow process modification, and shared decision-making interventions. Purposive sampling included persons with Type II diabetes, 18-75 years, presenting for an annual visit type encounter. Interventions: Rule query preference entry and workflow process modification were monitored to a short-term goal benchmark of 90% for completion of recommended testing for persons with Type II diabetes. Data collection evaluated generation of CDSS reminders and annual completion of comprehensive foot examinations, urine microalbumin to creatinine ratio testing, and dilated eye examinations. Results: A total of six patients participated in the project, n = 5 met criteria for Type II diabetes diagnosis, n = 1 miscoded. The EHR generated CDSS reminders, and staff completed annual comprehensive foot examinations 83.33% of eligible encounters. Urine microalbumin testing was completed 66.63% of eligible encounters with n = 1 (16.33%) deferred testing until their annual visit. Strengths emerging from Strengths, Weakness, Opportunities, and Threats (SWOT) analysis included simple streamlined guidelines that promote teamwork. Conclusion: Consistent CDSS reminder facilitates recommendation completion, benefiting patients and providers. Although short term goals were not achieved at the 90% benchmark, the project is deemed clinically significant representing the homogeneity of Montanans. Future recommendations include participation in Merit-based Incentive Payment System (MIPS), extension of interventions for utilization of other chronic diseases, and integration of Current Procedural Terminology (CPT) codes for reimbursement for services.en
dc.identifier.urihttps://scholarworks.montana.edu/handle/1/18510
dc.language.isoenen
dc.publisherMontana State University - Bozeman, College of Nursingen
dc.rights.holderCopyright 2024 by Brandi Lynn Flemingen
dc.subject.lcshType 2 diabetesen
dc.subject.lcshPrimary care (Medicine)en
dc.subject.lcshWorkflowen
dc.subject.lcshRural healthen
dc.subject.lcshWeatheren
dc.titleIncreasing recommended testing compliance for persons with type II diabetes in primary careen
dc.typeDissertationen
mus.data.thumbpage23en
thesis.degree.committeemembersMembers, Graduate Committee: Alice Runningen
thesis.degree.departmentNursing.en
thesis.degree.genreDissertationen
thesis.degree.nameDoctor of Nursing Practice (DNP)en
thesis.format.extentfirstpage1en
thesis.format.extentlastpage89en

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
fleming-increasing-2024.pdf
Size:
1.84 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
825 B
Format:
Plain Text
Description:
Copyright (c) 2002-2022, LYRASIS. All rights reserved.